Vedolizumab is a gut-selective humanized monoclonal antibody that has recently been made available in the US and the EU, and also approved in Australia under the trade name
Bioceltran is focused on Protein Transduction Domain (PTD) Technology for transdermal delivery of drugs for cosmetics and pharmaceuticals. Following the signing the license deal, Quest purchased 38% ownership
The patient who arrived from Liberia, West Africa on 20 September sought for medical care at Texas Health Presbyterian Hospital of Dallas on 24 of the same month.
Under the deal, Fast Forward will provide funding to Glialogix for preclinical studies of GLX1112, a first-in-class neuroprotective therapy designed to slow the accumulation of disability in progressive
The new indication of XTANDI, an oral, once-daily androgen receptor inhibitor capsule, is for treatment of CRPC patients who have not received chemotherapy. XTANDI is currently available for
The acquisition, which will strengthen J&J’s existing pipeline in viral diseases, will include Alios’ portfolio of potential therapeutics for viral infections including compound AL-8176, an orally administered antiviral
Surgex Warrior is packed with next generation nutraceuticals and whole food extracts, and is currently available at Winn-Dixie’s 700+ locations in the US. The product is designed to
The expansion is expected to help the pharmaceutical company in creating about 100 new jobs at its Dortmund site. Boehringer Ingelheim member of the Board of Managing Directors
Dupilumab is an investigational therapy that blocks IL-4 and IL-13 signaling. The results showed that dupilumab met all primary and secondary endpoints in these patients who did not
The trial is designed to assess the efficacy of DanDrit’s vaccine MelCancerVac (MCV) in stage IV CRC patients rendered disease free after the completion of standard treatments in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.